Leaderboards/autoimmune neurological disorders and treatments

autoimmune neurological disorders and treatments

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Anahita Asadi
Howard University
99
2
Pradeep K. Karla
Howard University
90
3
Marie‐Louis Wronski
Harvard University
80
4
Lisa Dinkler
Karolinska Institutet
70
5
R. Mountford
University of Liverpool
40
6
Andreas Göebel
University of Liverpool
30
7
Юрій Тітаренко
European Academy of Technology and Innovation Assessment
20
8
Jinhe Zhang
Capital Medical University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Volkan Granit
University of Miami
99
2
Emily Van San
VIB-UGent Center for Inflammation Research
90
3
David C. Whitcomb
University of Pittsburgh
80
4
Silvia Casagrande
Provincia Autonoma di Trento
70
5
Jeremias Motte
St. Josef-Hospital
60
6
Angel A Justiz-Vaillant
University of the West Indies
40
7
Zuber Khan
Punjab Technical University
30
8
Vincenzo Di Stefano
University of Palermo
20
9
Yuanyuan Xie
Dalian Medical University
10

Emerging Leaders Papers

1
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections
Endocrine Metabolic & Immune Disorders - Drug Targets|2025
8 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Karin Jordan
University Hospital Heidelberg
99
2
David R. Lynch
University of Pennsylvania
90
3
Michael L. Schilsky
University Medical Center
80
4
Shuu‐Jiun Wang
National Yang Ming Chiao Tung University
70
5
Maxime Seligmann
Unknown
60
6
Lorraine Lougee
Unknown
50
7
Mary‐Claire King
University of Washington
40
8
Josep Dalmau
University of Pennsylvania
30
9
Georgina V. Long
The University of Sydney
20
10
Jenny Heathcote
Toronto Western Hospital
10

All-Time Leaders Papers

1
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Nature Communications|2014
385 cit.
2
Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain
Journal of Neuroscience|2012
284 cit.
3
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Nature Medicine|2025
55 cit.
4
Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
PLoS ONE|2014
51 cit.
5
Functional Characterization of Parallel Fiber-Purkinje Cell Synapses in Two Friedreich’s Ataxia Mouse Models
The Cerebellum|2025
2 cit.

Reagents for autoimmune neurological disorders and treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

Paip2A Antibody

#4422$317
View Evidence →Cell Signaling Technology

K48-linkage Specific Polyubiquitin (D9D5) Rabbit Monoclonal Antibody (HRP Conjugate)

#12805$493
View Evidence →Cell Signaling Technology

SMCHD1 (F7U9Y) Rabbit Monoclonal Antibody

#30566$161
View Evidence →

🌟 All-Time

Most validated

Millipore

Anti-NMDAR1

#AB9864
View Evidence →Bio-Rad

Trans-Blot Turbo Nitrocellulose Transfer Packs, Mini

#1704158
View Evidence →Millipore

Anti-NR1 Antibody, CT,

#05-432
View Evidence →